Plasma protein fractionation

The fractionation of blood plasma yields a number of therapeutic proteins which together constitute a billion dollar world-wide market. Conventional plasma fractionation procedures are being replaced by more sophisticated chromatographic techniques. The application of genetic engineering and these new downstream processing techniques is likely to lead to improved products of higher purity and stability, with less likelihood of contamination by viruses and at lower cost per therapeutic dose.